Search
Pandemic Planning and Implementation
January 20th, 2009 Bridging Medical Needs in the Context of an International Pandemic Dr. John Spika : Director, Bureau of Infectious Diseases, Centre for Infectious Disease Prevention and Control, Public Health Agency of Canada, Ottawa, Ontario, Canada …
Suboptimal, inconsistent treatment for anaphylaxis due to unknown cause
December 20th, 2018 Releases Research MONTREAL, QC - A new Canadian study, led by a team at the Research Institute of the McGill University Health Centre (RI-MUHC), is shedding light on anaphylaxis due to an unknown trigger (AUT)—an unpredictable and …
Montréal sans HépC: a fight to eliminate HCV in Montreal
July 26th, 2019 News Articles To highlight World Hepatitis Day, the McGill University Health Centre (MUHC) is proud to share some exciting news: the launch of Montréal sans HépC , an initiative to make Montreal the first city in North America to …
Sleuths at the MUHC: the essential role of Infection and Prevention Control
August 8th, 2019 News Articles For some staff at the MUHC, the Infection Prevention and Control (IPC) Services are responsible for making sure you’ve washed your hands and disinfected all surfaces. But the dedicated teams of twelve specialists and four …
Sepsis: testing before starting treatment is essential
September 18th, 2019 Research Releases News Given that timely administration of appropriate antibiotics is essential to prevent death in patients with severe infections, can healthcare teams “skip” drawing blood for bacterial cultures and go straight to …
RI-MUHC researcher Nitika Pant Pai advocates improved access to HIV self-testing for Canadians
December 1st, 2020 News Research Canada approves HIV self-testing kit ahead of World AIDS Day 2020 Source: CMAJ and RI-MUHC. People with HIV can live long and healthy lives. A test, diagnosis, and connection to appropriate care and services are …
Low-Income HIV Patients Suffer with Healthcare Access
April 18th, 2018 Releases Montreal — Quebecers do not have equal access to anti-retroviral treatment (ART) for HIV and AIDS, a long-term study undertaken by a team from the Research Institute of the McGill University Health Centre (RI-MUHC) in …
Complete make-over in fight of multidrug-resistant tuberculosis
September 6th, 2018 Releases Research Montreal – Several new medicines have been found to be more effective than traditional ones used to treat multidrug-resistant tuberculosis (MDR-TB), according to a new international collaborative study led by Dr. Dick …
Latent TB Treatment: Shorter is Better
August 1st, 2018 Releases Research Montreal – Treatment of latent tuberculosis is set to transform after a pair of studies from the Research-Institute of the McGill University Health Centre (RI-MUHC) revealed that a shorter treatment was safer and more …